New York, NY (PRWEB) February 24, 2014
Thousands of recently-filed Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) are alleging that certain researchers and medical institutions may have concealed vital safety data about the blood-thinner in clinical trials that led to its U.S. approval, Bernstein Liebhard LLP reports.
According to a February 15th report from The Spectator.com, many of the 2,300 cases now pending in U.S. federal and state courts claim that affiliates of a medical group and public research university in Canada failed to adequately design and administer the clinical trials that assisted in Pradaxa’s approval process through the U.S. Food and Drug Administration (FDA).*
Among other things, plaintiffs in these lawsuits allege that researchers also failed to properly maintain data related to the trials, as well as report serious adverse event reports that may have been associated with the blood thinner. Boehringer-Ingelheim, the German company who developed Pradaxa, is partially blamed for the serious and potentially-life threatening internal bleeding injuries alleged in lawsuits now filed in a federal multidistrict litigation underway in the U.S. District Court, Southern District of Illinois. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)
“These new developments in the federal Pradaxa lawsuit litigation are of great interest to our Firm, as we continue to hear from individuals and their families who allegedly sustained life-threatening episodes of internal bleeding stemming from use of the drug,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free and confidential case reviews to individuals who may be eligible to file Pradaxa lawsuits.
According to court records, Pradaxa lawsuits filed in the Southern District of Illinois are continuing to move forward. A Case List updated on February 19th by the U.S. Judicial Panel on Multidistrict Litigation indicates that 2,072 cases have now been filed in the federal litigation on behalf of individuals and their estates who claim that Boehringer-Ingelheim failed to inform patients and their doctors that there is no readily available antidote for reversing Pradaxa internal bleeding side effects. Meanwhile, episodes of internal bleeding associated with the decades-old blood thinner, warfarin, can be stopped with the administration of vitamin K. A Reuters report published earlier in February indicates that Boehringer has acknowledged its involvement in Pradaxa bleeding lawsuits, but maintains that its benefits in preventing strokes in patients with atrial fibrillation should be weighed against side effects they say were known.**
Pradaxa was the first anticoagulant to be approved by the FDA since warfarin, according to the February 13th report.
Patients who may have experienced life-threatening internal bleeding injuries after taking this blood thinner may be eligible to file a Pradaxa lawsuit against Boehringer-Ingelheim. Learn more about this medication’s side effects by visiting Bernstein Liebhard LLP’s website, or by scheduling a free and confidential case evaluation with one of our attorneys at 800-511-5092.
*http://www.thespec.com/news-story/4369907-trial-and-errors-mac-hhs-sued-over-drug-safety/, TheSpec.com, February 15, 2014
**uk.reuters.com/article/2014/02/13/us-boehringer-pradaxa-idUKBREA1C0PW20140213, Reuters, February 13, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com